Custom Pharma Services
Lisa C. has extensive experience in the pharmaceutical industry, having served in various leadership roles at Custom Pharma Services since August 2008, including Head of Logistics, Safety and Wellbeing, and multiple positions focused on Safety, Health, and Environment management. Lisa's responsibilities have involved ensuring compliance with legal requirements and maintaining high standards of quality assurance across packaging and warehouse operations, alongside conducting batch reviews and managing QA activities. Prior to Custom Pharma Services, Lisa worked at Allergy Therapeutics from July 2003 to August 2008, where responsibilities included leading a team in the Inspection, Labelling, and Packaging department, as well as overseeing sterile product filling processes. Lisa's educational background includes training from Skills Training UK and attendance at Davison C of E High School for Girls.
This person is not in any teams
Custom Pharma Services
1 followers
Custom Pharma Services is located in Brighton, UK since 1979 and is a full-service contract development and manufacturing organisation (CDMO) providing services tailored to your needs, no matter how niche or complex. Custom covers the full spectrum of activities from development through commercial manufacturing for both clinical and commercial use. Specialising in Oral Solid Dosage forms with the ability to handle highly potent drugs and poorly bioavailable compounds Custom really is your one stop resource. With direct access to highly skilled experts offering a partnership approach Custom Pharma Services truly has a molecule first mentality, managing all projects with the end in mind. Custom Can! • Custom Pharma is a CDMO offering clinical and commercial manufacturing of tablets, capsules, powders (oral-solid-dose) for human use. • Services comprise pre-formulation and formulation development, analytical development, stability testing, clinical trial material manufacturing • Commercial Production • Pre-clinical formulation development and solubilisation • Material characterisation • Drug in capsule approach to accelerate early clinical studies • Specialists in low dosage (sub-mg) formulations • Contained manufacturing for highly potent APIs • Orphan drug development • Formulation development of poorly soluble drugs, including spray drying capabilities